CBT4CBT web-based add-on treatment for cocaine use disorder: Study protocol for a randomized controlled trial
Por:
Mallorquí-Bagué N., Palazón-Llecha A., Madre M., Batlle F., Duran-Sindreu S., Trujols J.
Publicada:
2 mar 2023
Ahead of Print:
2 mar 2023
Resumen:
Background: Cocaine use disorder (CUD) is a chronic condition that presents high relapse rates and treatment dropouts. Web-based interventions have proven to be effective when optimizing face-to-face treatments in different mental health conditions and have the potential to optimize current CUD treatments. However, web-based interventions in addictive behaviors are still limited. The aim of this study is to evaluate whether adding a web-based cognitive behavioral therapy (i.e., CBT4CBT) to standard CUD treatment, improves treatment outcomes in a Spanish sample of patients with severe CUD (which requires inpatient treatment). Additionally, we aim to explore predictive factors of treatment response and treatment gender-related differences.Methods: All individuals coming for inpatient cocaine detoxification who meet the inclusion criteria will have the possibility to be part of the study. The participants of this open-label randomized controlled clinical trial (RCT) will be allocated to treatment as usual (TAU) or TAU+CBT4CBT after the hospitalization for cocaine detoxification. During the inpatient treatment they will all receive an individualized psychological intervention. There will be six time point assessments: at 48-72 h of starting inpatient treatment, at the end of inpatient treatment and before starting day care and outpatient treatment, at the end of the 8 weeks CTB4CBT / TAU arm treatment and at three follow-up time points (1-, 3-, and 6-months post-treatment).Discussion: To the best of our knowledge, this is the first RCT that explores the efficacy of adding a web-based cognitive behavioral therapy to usual CUD treatment with patients of a clinical sample in Europe.
Filiaciones:
Mallorquí-Bagué N.:
Hosp Sant Creu & St Pau, Biomed Res Inst St Pau IIB St Pau, Dept Psychiat, Addict Behav Unit, Barcelona, Spain
Univ Girona, Dept Psychol, Girona, Spain
Palazón-Llecha A.:
Hosp Sant Creu & St Pau, Biomed Res Inst St Pau IIB St Pau, Dept Psychiat, Addict Behav Unit, Barcelona, Spain
Univ Girona, Dept Psychol, Girona, Spain
Madre M.:
Hosp Sant Creu & St Pau, Biomed Res Inst St Pau IIB St Pau, Dept Psychiat, Addict Behav Unit, Barcelona, Spain
Batlle F.:
Hosp Sant Creu & St Pau, Biomed Res Inst St Pau IIB St Pau, Dept Psychiat, Addict Behav Unit, Barcelona, Spain
Duran-Sindreu S.:
Hosp Sant Creu & St Pau, Biomed Res Inst St Pau IIB St Pau, Dept Psychiat, Addict Behav Unit, Barcelona, Spain
Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain
Trujols J.:
Hosp Sant Creu & St Pau, Biomed Res Inst St Pau IIB St Pau, Dept Psychiat, Addict Behav Unit, Barcelona, Spain
Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid, Spain
Green Published, gold, All Open Access, Gold, Green
|